Click for best price
Postpemic Era Cholera Vaccines Market Size, Share 2022
Summary
The global and Chinese economies were hit hard in 2020, and the global GDP grew by 5.9% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really recovered to the level before the epidemic. The vast majority of countries are still in the stage of recovery after heavy damage and are far from achieving real recovery.
2022 is a year of continuous recovery. Global supply chain disturbance, geopolitical tension, energy price fluctuation, local labor shortage and rising raw material prices will affect the resilience of economic recovery. The International Monetary Fund (IMF) predicts that the world economy will grow by 4.4% in 2022, of which the U.S. economy will grow by about 4%. Driven by China and India, Asia is expected to become the fastest growing region in the world in 2022. However, China's economic growth has slowed down. The 2022 government work report shows that the expected target of economic growth is set at about 5.5%.
According to research, China has set a growth rate of about 5.5%, which not only focuses on the speed of economic growth, but also anchors the quality of economic development. Scientific and technological innovation, economic and social digitization and green development will be the long-term goals of China's economic development. It is expected that in 2022, major economies such as the United States, Europe and China will introduce more favorable policies to drive the development of switching power supply industry.
(Post-pandemic Era)-Global Cholera Vaccines Market Segment Research Report 2022?, which aims to sort out the development status and trends of the Cholera Vaccines industry at home and abroad, estimate the overall market scale of the Cholera Vaccines industry and the market share of major countries, Cholera Vaccines industry, and study and judge the downstream market demand of Cholera Vaccines through systematic research, Analyze the competition pattern of Cholera Vaccines, so as to help solve the pain points of various stakeholders in Cholera Vaccines industry. This industry research report combines desktop research, qualitative interviews with insiders or experts and other methods to strive for the objectivity and integrity of conclusions and data.
Regional Segmentation (Value; Revenue, USD Million, 2018-2028) of Cholera Vaccines Market by Research Include
USA
Europe
China
Japan
India
Korea
Southeast Asia
Competitive Analysis; Who are the Major Players in Cholera Vaccines Market?
Shantha Biotechnics Private Limited
PaxVax, Inc.
Valneva SE
Merck and Co., Inc.
GlaxoSmithKline plc (GSK)
Astellas Pharma, Inc.
Pfizer, Inc.
Emergent BioSolutions, Inc.
Mitsubishi Tanabe Pharma Corporation
Takeda Pharmaceutical Co., Ltd.
Major Type of Cholera Vaccines Covered in Research report:
Dukoral
Shanchol
Vaxchora
Others
Application Segments Covered in Research Market
Oral
Others
For any other requirements, please feel free to contact us and we will provide you customized report.
| Report Attributes |
Report Details |
| Report Title |
(Post-pandemic Era)-Global Cholera Vaccines Market Segment Research Report 2022 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
83 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
Table of Contents
Global Cholera Vaccines Market Segment Research Report 2022
1. Research Scope
2. Market Overview
2.1 Product Introduction, Application, Picture
2.2 Global Cholera Vaccines Market by Value
2.2.1 Global Cholera Vaccines Revenue by Type
2.2.2 Global Cholera Vaccines Market by Value
2.3 Global Cholera Vaccines Market by Sales
2.3.1 Global Cholera Vaccines Sales by Type
2.3.2 Global Cholera Vaccines Market by Sales
3. The Major Driver of Cholera Vaccines Industry
3.1 Historical & Forecast Global Cholera Vaccines Sales and Revenue (2018-2028)
3.2 Largest Application for Cholera Vaccines (2018-2028)
3.3 The Major Downstream Company in China Market 2022
4. Global and Regional Cholera Vaccines Market
4.1 Regional Market Size in Terms of Sales (2022 & 2028)
4.2 Regional Market Share in Terms of Revenue (2022 & 2028)
4.3 Concentration Ratio (CR5& CR10) of Cholera Vaccines Market
4.4 Mergers & Acquisitions, Expansion Plans
5. US Cholera Vaccines Sales (2018-2028)
5.1 Current and Estimated Sales Breakdown by Type (2018-2028)
5.2 Current and Estimated Sales Breakdown by Application (2018-2028)
5.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
5.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
6. Europe Cholera Vaccines Sales (2018-2028)
6.1 Current and Estimated Sales Breakdown by Type (2018-2028)
6.2 Current and Estimated Sales Breakdown by Application (2018-2028)
6.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
6.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
7. China Cholera Vaccines Sales (2018-2028)
7.1 Current and Estimated Sales Breakdown by Type (2018-2028)
7.2 Current and Estimated Sales Breakdown by Application (2018-2028)
7.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
7.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
8. Japan Cholera Vaccines Sales (2018-2028)
8.1 Current and Estimated Sales Breakdown by Type (2018-2028)
8.2 Current and Estimated Sales Breakdown by Application (2018-2028)
8.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
8.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
9. India Cholera Vaccines Sales (2018-2028)
9.1 Current and Estimated Sales Breakdown by Type (2018-2028)
9.2 Current and Estimated Sales Breakdown by Application (2018-2028)
9.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
9.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
10. Korea Cholera Vaccines Sales (2018-2028)
10.1 Current and Estimated Sales Breakdown by Type (2018-2028)
10.2 Current and Estimated Sales Breakdown by Application (2018-2028)
10.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
10.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
11. Southeast Asia Cholera Vaccines Sales (2018-2028)
11.1 Current and Estimated Sales Breakdown by Type (2018-2028)
11.2 Current and Estimated Sales Breakdown by Application (2018-2028)
11.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
11.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
12. South America Cholera Vaccines Sales (2018-2028)
12.1 Current and Estimated Sales Breakdown by Type (2018-2028)
12.2 Current and Estimated Sales Breakdown by Application (2018-2028)
12.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
12.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
13. Global Cholera Vaccines Average Price Trend
13.1 Market Price for Each Type of Cholera Vaccines in US (2018-2022)
13.2 Market Price for Each Type of Cholera Vaccines in Europe (2018-2022)
13.3 Market Price for Each Type of Cholera Vaccines in China (2018-2022)
13.4 Market Price for Each Type of Cholera Vaccines in Japan (2018-2022)
13.5 Market Price for Each Type of Cholera Vaccines in India (2018-2022)
13.6 Market Price for Each Type of Cholera Vaccines in Korea (2018-2022)
13.7 Market Price for Each Type of Cholera Vaccines in Southeast Asia (2018-2022)
13.8 Market Price for Each Type of Cholera Vaccines in South America (2018-2022)
14. Industrial Chain (Impact of COVID-19)
14.1 Cholera Vaccines Industrial Chain Analysis
14.2 Downstream
14.3 Impact of COVID-19
14.4 Post-pandemic Era
14.5 Technology Trends of Cholera Vaccines
15. Cholera Vaccines Competitive Landscape
15.1 Shantha Biotechnics Private Limited
15.1.1 Shantha Biotechnics Private Limited Company Profiles
15.1.2 Shantha Biotechnics Private Limited Product Introduction
15.1.3 Shantha Biotechnics Private Limited Cholera Vaccines Sales, Revenue (2018-2022)
15.1.4 Strategic initiatives
15.2 PaxVax, Inc.
15.2.1 PaxVax, Inc. Company Profiles
15.2.2 PaxVax, Inc. Product Introduction
15.2.3 PaxVax, Inc. Cholera Vaccines Sales, Revenue (2018-2022)
15.2.4 Strategic initiatives
15.3 Valneva SE
15.3.1 Valneva SE Company Profiles
15.3.2 Valneva SE Product Introduction
15.3.3 Valneva SE Cholera Vaccines Sales, Revenue (2018-2022)
15.3.4 Strategic initiatives
15.4 Merck and Co., Inc.
15.4.1 Merck and Co., Inc. Company Profiles
15.4.2 Merck and Co., Inc. Product Introduction
15.4.3 Merck and Co., Inc. Cholera Vaccines Sales, Revenue (2018-2022)
15.4.4 Strategic initiatives
15.5 GlaxoSmithKline plc (GSK)
15.5.1 GlaxoSmithKline plc (GSK) Company Profiles
15.5.2 GlaxoSmithKline plc (GSK) Product Introduction
15.5.3 GlaxoSmithKline plc (GSK) Cholera Vaccines Sales, Revenue (2018-2022)
15.5.4 Strategic initiatives
15.6 Astellas Pharma, Inc.
15.6.1 Astellas Pharma, Inc. Company Profiles
15.6.2 Astellas Pharma, Inc. Product Introduction
15.6.3 Astellas Pharma, Inc. Cholera Vaccines Sales, Revenue (2018-2022)
15.6.4 Strategic initiatives
15.7 Pfizer, Inc.
15.7.1 Pfizer, Inc. Company Profiles
15.7.2 Pfizer, Inc. Product Introduction
15.7.3 Pfizer, Inc. Cholera Vaccines Sales, Revenue (2018-2022)
15.7.4 Strategic initiatives
15.8 Emergent BioSolutions, Inc.
15.8.1 Emergent BioSolutions, Inc. Company Profiles
15.8.2 Emergent BioSolutions, Inc. Product Introduction
15.8.3 Emergent BioSolutions, Inc. Cholera Vaccines Sales, Revenue (2018-2022)
15.8.4 Strategic initiatives
15.9 Mitsubishi Tanabe Pharma Corporation
15.9.1 Mitsubishi Tanabe Pharma Corporation Company Profiles
15.9.2 Mitsubishi Tanabe Pharma Corporation Product Introduction
15.9.3 Mitsubishi Tanabe Pharma Corporation Cholera Vaccines Sales, Revenue (2018-2022)
15.9.4 Strategic initiatives
15.10 Takeda Pharmaceutical Co., Ltd.
15.10.1 Takeda Pharmaceutical Co., Ltd. Company Profiles
15.10.2 Takeda Pharmaceutical Co., Ltd. Product Introduction
15.10.3 Takeda Pharmaceutical Co., Ltd. Cholera Vaccines Sales, Revenue (2018-2022)
15.10.4 Strategic initiatives
16. Conclusion
17. Methodology and Data Source
LIST OF TABLES & FIGURES
List of Tables and Figures
Figure 1. Total Sales by Application of Cholera Vaccines Industry (Volume)
Figure 2. Cholera Vaccines Sales by Regions in 2022
Figure 3. Regional Market Share in Terms of Revenue (2022&2028)
Figure 4. The Top 10 and 5 Players Market Share by Cholera Vaccines Revenue in 2022
Figure 5. US Cholera Vaccines Sales (2018-2028)
Figure 6. Sales Breakdown by Type (%)
Figure 7. Sales Breakdown by Type (%)
Figure 8. Sales Breakdown by Application (%)
Figure 9. Revenue Breakdown by Type (%)
Figure 10. Revenue Breakdown by Application (%)
Figure 11. Europe Cholera Vaccines Sales (2018-2028)
Figure 12. Sales Breakdown by Type (%)
Figure 13. Sales Breakdown by Type (%)
Figure 14. Sales Breakdown by Application (%)
Figure 15. Revenue Breakdown by Type (%)
Figure 16. Revenue Breakdown by Application (%)
Figure 17. China Cholera Vaccines Sales (2018-2028)
Figure 18. Sales Breakdown by Type (%)
Figure 19. Sales Breakdown by Type (%)
Figure 20. Sales Breakdown by Application (%)
Figure 21. Current and Estimated Revenue Breakdown by Type
Figure 22. Revenue Breakdown by Type (%)
Figure 23. Revenue Breakdown by Application (%)
Figure 24. Japan Cholera Vaccines Sales (2018-2028)
Figure 25. Sales Breakdown by Type (%)
Figure 26. Sales Breakdown by Type (%)
Figure 27. Sales Breakdown by Application (%)
Figure 28. Revenue Breakdown by Type (%)
Figure 29. Revenue Breakdown by Application (%)
Figure 30. India Cholera Vaccines Sales (2018-2028)
Figure 31. Sales Breakdown by Type (%)
Figure 32. Sales Breakdown by Type (%)
Figure 33. Sales Breakdown by Application (%)
Figure 34. Revenue Breakdown by Type (%)
Figure 35. Revenue Breakdown by Application (%)
Figure 36. Korea Cholera Vaccines Sales (2018-2028)
Figure 37. Sales Breakdown by Type (%)
Figure 38. Sales Breakdown by Type (%)
Figure 39. Sales Breakdown by Application (%)
Figure 40. Revenue Breakdown by Type (%)
Figure 41. Revenue Breakdown by Application (%)
Figure 42. Southeast Asia Cholera Vaccines Sales (2018-2028)
Figure 43. Current and Estimated Sales Breakdown by Type (2018-2028)
Figure 44. Sales Breakdown by Type (%)
Figure 45. Sales Breakdown by Type (%)
Figure 46. Revenue Breakdown by Type (%)
Figure 47. Revenue Breakdown by Application (%)
Figure 48. Industrial Chain
Table 1. Top Manufacturers and Market Segmentation
Table 2. Product Introduction, Application, Picture
Table 3. Cholera Vaccines Revenue, by Type (Million USD) (2018-2028)
Table 4. Cholera Vaccines Sales, by Type (K Unit) (2018-2028)
Table 5. Cholera Vaccines Sales (K Unit) by Application (2018-2028)
Table 6. Cholera Vaccines Sales (Million USD) by Application (2018-2028)
Table 7. The Major Downstream Company in China
Table 8. Regional Market Share in Terms of Sales (2022)
Table 9. Regional Market Share in Terms of Revenue (2022&2028)
Table 10. Ranking of Global Top Cholera Vaccines Companies by Revenue, Concentration Ratio in 2022
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. US Cholera Vaccines Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 13. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 14. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 15. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 16. Current and Estimated Revenue Breakdown by Type
Table 17. Current and Estimated Revenue Breakdown by Application
Table 18. Europe Cholera Vaccines Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 19. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 20. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 21. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 22. Current and Estimated Revenue Breakdown by Type
Table 23. Current and Estimated Revenue Breakdown by Application
Table 24. China Cholera Vaccines Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 25. Table Current and Estimated Sales Breakdown by Type
Table 26. Current and Estimated Sales Breakdown by Type
Table 27. Current and Estimated Sales Breakdown by Application
Table 28. Current and Estimated Revenue Breakdown by Application
Table 29. Japan Cholera Vaccines Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 30. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 31. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 32. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 33. Current and Estimated Revenue Breakdown by Type
Table 34. Current and Estimated Revenue Breakdown by Application
Table 35. India Cholera Vaccines Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 36. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 37. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 38. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 39. Current and Estimated Revenue Breakdown by Type
Table 40. Current and Estimated Revenue Breakdown by Application
Table 41. Korea Cholera Vaccines Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 42. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 43. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 44. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 45. Current and Estimated Revenue Breakdown by Type
Table 46. Current and Estimated Revenue Breakdown by Application
Table 47. Southeast Asia Cholera Vaccines Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 48. Table Current and Estimated Sales Breakdown by Type (2018-2028)
Table 49. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 50. Current and Estimated Revenue Breakdown by Type
Table 51. Current and Estimated Revenue Breakdown by Application
Table 52. Market Price (USD/Unit) for Each Type of Cholera Vaccines in US (2018-2022)
Table 53. Market Price (USD/Unit) for Each Type of Cholera Vaccines in Europe (2018-2022)
Table 54. Market Price (USD/Unit) for Each Type of Cholera Vaccines in China (2018-2022)
Table 55. Market Price (USD/Unit) for Each Type of Cholera Vaccines in Japan (2018-2022)
Table 56. Market Price (USD/Unit) for Each Type of Cholera Vaccines in India (2018-2022)
Table 57. Market Price (USD/Unit) for Each Type of Cholera Vaccines in Korea (2018-2022)
Table 58. Market Price (USD/Unit) for Each Type of Cholera Vaccines in Southeast Asia (2018-2022)
Table 59. Key Downstream Customer in Each Application Field
Table 60. Shantha Biotechnics Private Limited Profiles
Table 61. Shantha Biotechnics Private Limited Cholera Vaccines Product Introduction
Table 62. Shantha Biotechnics Private Limited Cholera Vaccines Sales (Unit), Revenue (Million USD) (2018-2022)
Table 63. Shantha Biotechnics Private Limited Strategic initiatives
Table 64. PaxVax, Inc. Profiles
Table 65. PaxVax, Inc. Cholera Vaccines Product Introduction
Table 66. PaxVax, Inc. Cholera Vaccines Sales (Unit), Revenue (Million USD) (2018-2022)
Table 67. PaxVax, Inc. Strategic initiatives
Table 68. Valneva SE Profiles
Table 69. Valneva SE Cholera Vaccines Product Introduction
Table 70. Valneva SE Cholera Vaccines Sales (Unit), Revenue (Million USD) (2018-2022)
Table 71. Valneva SE Strategic initiatives
Table 72. Merck and Co., Inc. Profiles
Table 73. Merck and Co., Inc. Cholera Vaccines Product Introduction
Table 74. Merck and Co., Inc. Cholera Vaccines Sales (Unit), Revenue (Million USD) (2018-2022)
Table 75. Merck and Co., Inc. Strategic initiatives
Table 76. GlaxoSmithKline plc (GSK) Profiles
Table 77. GlaxoSmithKline plc (GSK) Cholera Vaccines Product Introduction
Table 78. GlaxoSmithKline plc (GSK) Cholera Vaccines Sales (Unit), Revenue (Million USD) (2018-2022)
Table 79. GlaxoSmithKline plc (GSK) Strategic initiatives
Table 80. Astellas Pharma, Inc. Profiles
Table 81. Astellas Pharma, Inc. Cholera Vaccines Product Introduction
Table 82. Astellas Pharma, Inc. Cholera Vaccines Sales (Unit), Revenue (Million USD) (2018-2022)
Table 83. Astellas Pharma, Inc. Strategic initiatives
Table 84. Pfizer, Inc. Profiles
Table 85. Pfizer, Inc. Cholera Vaccines Product Introduction
Table 86. Pfizer, Inc. Cholera Vaccines Sales (Unit), Revenue (Million USD) (2018-2022)
Table 87. Pfizer, Inc. Strategic initiatives
Table 88. Emergent BioSolutions, Inc. Profiles
Table 89. Emergent BioSolutions, Inc. Cholera Vaccines Product Introduction
Table 90. Emergent BioSolutions, Inc. Cholera Vaccines Sales (Unit), Revenue (Million USD) (2018-2022)
Table 91. Emergent BioSolutions, Inc. Strategic initiatives
Table 92. Mitsubishi Tanabe Pharma Corporation Profiles
Table 93. Mitsubishi Tanabe Pharma Corporation Cholera Vaccines Product Introduction
Table 94. Mitsubishi Tanabe Pharma Corporation Cholera Vaccines Sales (Unit), Revenue (Million USD) (2018-2022)
Table 95. Mitsubishi Tanabe Pharma Corporation Strategic initiatives
Table 97. Takeda Pharmaceutical Co., Ltd. Profiles
Table 98. Takeda Pharmaceutical Co., Ltd. Cholera Vaccines Product Introduction
Table 99. Takeda Pharmaceutical Co., Ltd. Cholera Vaccines Sales (Unit), Revenue (Million USD) (2018-2022)
Table 100. Takeda Pharmaceutical Co., Ltd. Strategic initiatives
